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Optimal Treatment for Hemodialysis Patients with Critical Limb Ischemia;
Comparison Surgical and Endovascular Revascularization for Infrainguinal
Artery Disease
Tatsuya Shiraki,1 Osamu Iida1
1Kansai Rosai Hospital, Japan
BACKGROUND The number of patients on hemodialysis complicated
with critical limb ischemia (CLI) is increasing worldwide. Latest
guideline points to life expectancy of <2 years as main determinant in
revascularization modality selection (bypass surgery [BSX] or endo-
vascular therapy [EVT]) in patients with critical limb ischemia (CLI).We
compared clinical outcomes after EVT and after BSX, and examined
predictors of 2-year mortality after revascularization in this setting.
METHODS This is retrospective multicenter study. From 2007 to
2009, 246 consecutive CLI patients on hemodialysis (age, 6910 years;
70% male; 45%non-ambulatory status; 69% diabetics; 21% with rest
pain; and 79% with tissue loss) who underwent revascularization for
infrainguinal lesions (178 EVT and 68BSX) were enrolled. Two-year
amputation-free survival (AFS), overall survival (OS), major amputa-
tion (MA), and major adverse limb event (MALE: repeat EVT, surgical
reconstruction, major amputation) were evaluated by Kaplan-Meier
analysis. Predictors for 2-year mortality after revascularization were
determined using a Cox hazards model.
RESULTS Two-year AFS, OS, MA, and MALE rates were not signiﬁ-
cantly different between EVT and BSX (60% vs. 52%, P¼0.20; 80% vs.
69%, P¼0.18; 15% vs. 18%, P¼0.36; and 49% vs.42%, P¼0.40,
respectively), which held after adjustment with covariates. However,
death within 30 days was signiﬁcantly higher after BSX than EVT
(P¼0.048). Predictors of 2-year mortality after EVT or BSX were age
>75(hazard ratio [95% conﬁdence interval], 1.79 [1.09-2.93]), and
albumin<3g/dL (2.09 [1.21-3.59]).
CONCLUSION After revascularization in CLI patients on hemodialysis,
death ratewithin 30 dayswas higher in BSX than EVT; AFS, OS,MA, and
MALE rates were not signiﬁcantly different between EVT and BSX;
older age and low albumin level were associated with 2-year mortality.
TCTAP A-175
Catheter-Based Renal Denervation Could Lower Blood Pressure As Early
As One Month
Chuan Lei Chao,1 Po-Lin Lin,2 Tsung Yeh Yang,1 Chun-Wei Lee,1
Ying-Hsiang Lee1
1MacKay Memorial Hospital, Taiwan; 2MacKay Memorial Hospital,
Hsinchu, Taiwan
BACKGROUND Catheter-based renal sympathetic denervation (RDN)
has been shown to reduce blood pressure (BP) in resistant hyperten-
sion. Cohort of Symplicity HTN-3 study revealed discrepancy of
response between races. Our study was aimed to determine its efﬁ-
cacy in Taiwanese population.
METHODS Patients who received RDN and had ofﬁce BPat baseline, 3,
6 and 12 months after treatment were enrolled. Ambulatory 24-
hourBP monitoring (ABPM) and ofﬁce BP at 1 month was also
reviewed if available. Post procedure BP was compared to baseline.
Number and location of ablation under ﬂuoroscope were documented
to determine its impact on BP lowering.
RESULTS 72 patients (mean age 5711 years, 67% of male) had base-
line ofﬁce systolic BP 1682 mmHg, diastolic BP 9319 mmHg and
mean of 4.60.1 antihypertension medications. 1 patient had major
complication of vascular access hemorrhage without further sequelae.
Post procedure ofﬁce BPs were reduced by 21/5, 26/9, 23/9 mmHg at 3,
6, and 12 months (P<0.05), respectively. Among 36 patients with
ofﬁce BP at 1 month, 29 (81%) had >10mmHg of BP change and 22
(61%) had >20 mmHg. The response rate was seen persistently at 6
month. Fewer number of ablation was with less reduction in BP.
CONCLUSION For resistant hypertension, catheter-based sympa-
thetic RDN could achieve substantial reduction in BP. The efﬁcacy
could be seen as early as one month.
STRUCTURAL HEART DISEASE, OTHER (TCTAP A-176)TCTAP A-176
Who Are the Patients That Improved Cardiac Function in Acute Heart
Failure with Reduced LV EF?
Song-Yi Kim,1 Joon Hyouk Choi,1 Ki-Seok Kim,1 Seung-Jae Joo1
1Jeju National University Hospital, Korea (Republic of)BACKGROUND Recovery of LV EF is the goal of treatment in HF with
reduced EF. We thought that patients with HF who recovered LV
function (HF-recovered) have different characteristics. We sought to
characterize the HF-Recovered population and their prognosis.
METHODS We enrolled 227 patients with AHF with reduced EF who
were residents of Jeju Island from 2005 to 2013. They were divided
into two groups; HF-recovered (F/U EF 50% but initial EF
was <50%,N¼40, 17.6%). and HF with reduced EF (HFrEF, Initial and
F/U EF were both<50%, N¼187, 82.4%). Clinical characteristics and
laboratory ﬁndings were reviewed from medical records. They were
followed at least 2yrs. Clinical end-points were death or readmission
due to congestive HF (CHF).
RESULTS HF-recovered group were younger (63.615.57 vs.
73.4  13.57,p<0.001), and they had lower peak CKMB(5.64.64
vs.19.7966.58, p¼0.038), troponin-T (0.050.13 vs. 0.780.06,
p¼0.008) and proBNP level (5091.64876.5 vs. 8486.1  8884.9,
p¼0.002). In HF-Recovered group, most common etiology of HF was
dilated cardiomyopathy (N¼13, 32.5%). On the other hand, that was is
chemic heart disease in HFrEF group (N¼89, 47.6%) HF-recovered
patients also had a lower prevalence of coronary artery disease
requiring revascularization and consequently fewer with an ischemic
origin than HF-REF. Prevalence of hypertension, DM, CKD were
similar in both groups. 1-year survival rate of HF-recovered group was
signiﬁcant higher than HFrEF group (97.5% vs. 85.5%, p¼0.039), but
2-year survival rate was not different from that of HFrEF (90% vs.
79.6%, p¼0.113). 2-year CHF-free survival rate was not different in
both groups (70% vs. 67%, p¼0.634).
CONCLUSION In the patients of AHF with reduced EF, small portion
of patients had recovery of LV function. HF-recovered patients are
younger and associated with a better cardiac biomarker proﬁle. Their
etiology of HF was non-ischemic.
Their short-termprognosis were better than those of HFrEF patients,
but mid-term prognosis were similar.
TRANSRADIAL INTERVENTION
(TCTAP A-177 TO TCTAP A-178)
TCTAP A-177
Multi-Slice Computed Tomography Coronary Angiography for Detection of
Coronary Anomalies
Xuguang Qin1
1Hospital of Tsinghua University, China
BACKGROUND Congenital coronary artery anomaly occurs infre-
quently in general population, and they are present at birth, but
relatively few are symptomatic during childhood. Most coronary
anomalies are discovered as incidental ﬁndings during coronary
angiography. Their clinical relevance varies widely. They may be
clinically silent and totally benign, or may cause many adverse clinical
events and even sudden cardiac death resulting insigniﬁcant
morbidity and mortality, even among young adults.1, 2Cardiac cathe-
terization has traditionally been indicated to demonstrate the coro-
nary vasculature in detail and has remained the reference standard
imaging modality. Owing to the potentially complex three dimen-
sional anatomy of the coronary anomaly, conventional angiography,
not infrequently, incompletely delineates the anatomical course of
the coronary anomaly (3). This study sought to determine the ability
of MSCT to detect the origin and course of anomalous coronary artery.
METHODS From January 2007 to September 2010, we enrolled 16
consecutive patients primarily with suspected coronary artery disease
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Patients were eligible if they were  18 years of age. Patients with
atrial ﬁbrillation, contraindication to iodinated contrast agents, and
serum creatinine values >1.4 mg/dl were excluded.
Coronary angiography was performed using standard 6Fr coronary
catheters through trans-femoral or trans-radial approach. Coronary
angiograms were evaluated by 2 experienced, independent observers.
Coronary arteries were segmented according to guidelines of the
American Heart Association 18 (modiﬁed 16-segment model, with
segment 17 being intermediated branch of the left coronary artery).
12 patients were investigated by MSCT (Philips, 64 Slice, Philips,
USA). After determination of the contrast agent transit time, a volume
dataset was acquired (collimation 2640.6 mm, z-ﬂying focal spot,
gantry rotation time ms, tube current 400mAs/rotation, tube voltage
120kV) without application additional b-blocker medication to control
heart rate. Contrast agent (60 to 80 ml, iodine 350 mg/ml) was injected
at a ﬂow rate of 5 ml/s. All scans were performed using electrocar-
diographically gated tube current modulation. Maximal tube current
was limited to an interval 30% to 70% of cardiac cycle. Trans-axial
images were reconstructed with 0.75-mm slice thickness, 0.5-mm
increment, and a medium soft convolution kernel (B26f). The position
of the reconstruction window within the cardiac cycle was individu-
ally selected to minimize motion artifacts. The best dataset was used
for subsequent analysis.
RESULTS In total, 16 consecutive patients (75%men, mean ages
65years) with coronary artery diseases who underwent coronary
angiography were included in the study. Six cases of single coronary
artery (SCA) were found: including three cases of anomalous right
coronary artery (RCA) originating from the proximal or mid of left
descending coronary artery; left main coronary artery (LMCA) arising
from the proximal right coronary artery one case; anomalous RCA
originating from the distal of left circumﬂex (LCX) artery two cases.
Ten cases of anomalous RCA were detected: including anomalous RCA
arising from anterior wall of ascending aorta six cases and left sinus of
Valsalva four cases respectively. Multi-slice computed tomography
(MSCT) detected the origin and course of the anomalous coronary
artery in 12 of 16 patients (75%).
CONCLUSION Coronary angiography is essential detecting methods
to ﬁnd coronary anomalies and MSCT clearly depict the origin and
course of the anomalous coronary artery.
Keywords: MSCT. Coronary artery anomalies. Coronary angiography.
TCTAP A-178
Primary PCI with “Single” Catheter
Sho Torii,1 Yuji Ikari1
1Tokai University School of Medicine, Japan
BACKGROUND The beneﬁt of primary percutaneous coronary inter-
vention (PCI) for acute ST segment elevation myocardial infarction
(STEMI)is well documented and is closely tied to the door to balloon
(DTB) time. To shorten the DTB time, we perform diagnostic angiog-
raphy with IL-4.0 guiding catheter (Heartrail, Terumo Corporation,
Tokyo, Japan) because we can switch to the primary PCI immediately
following the full coronary angiogram with a single catheter.
METHODS We studied consecutive 31 STEMI patients who underwent
primary PCI at our hospital from November 1st 2013 to November 15th
2014. All patients were radial artery approach and the patients with
shock vital were excluded. Eight patients were performed diagnostic
angiography withIL-4.0 (IL group), and other 23 patients were per-
formed with JL-4.0, and JR-4.0(standard group). The cath lab to ﬁrst
device time was calculated.
RESULTS The cath lab to ﬁrst device time was signiﬁcantly faster in IL
group comparedwith standard group (19.5min vs. 38.3min, p¼0.0001).
CONCLUSION For STEMI patients, IL-4.0 catheter angiography
shortens the DTB time and may improve the patients’ outcome.
VALVULAR HEART DISEASE
(TCTAP A-179 TO TCTAP A-182)
TCTAP A-179
Acute Complications Following Balloon Mitral Valvuloplasty – Analysis of
1450 Cases over 15-Year Period
Ajith Ananthakrishna Pillai,1 Anupriya Annapurni,2
Chandramohan Ramasamy1
1Jawaharlal Institute of Post Graduate Medical Education and Research,
India; 2Chesterﬁeld Royal Hospital, United KingdomBACKGROUND Balloon mitral valvuloplasty (BMV) has in vogue for
more than 3 decades. The complications of the procedure are well
known. Few studies have analyzed the complications and its out-
comes following BMV in a large cohort.
METHODS Single center retrospective data analysis of acute compli-
cations following BMV for 15years from 1998-2012.The study looked in
to immediate 30 day outcomes following BMV. The data were retro-
spectively collected from hospital records.
RESULTS Data was available in 1450 patients (females 986) who un-
derwent BMV. Mean age of patients was 23.7 years (SD 5.8) (range
9-57 years) with mean follow up period of 9.7 years (SD 4.6). Inter-
vention resulted in successful BMV (more than 50% reduction in
baseline gradient) in 1294(94%) subjects and partially successful BMV
(20-50% reduction in baseline gradient) in 105 (6%) subjects. BMV
failed in 51 patients. Mitral regurgitation (MR) was observed in 76
patients (3.85%). But acute severe mitral regurgitation requiring
mitral valve replacement was noticed in 26 (1.79%) patients. On uni-
variate analysis female sex, age 40 years, eccentric valve calciﬁca-
tion and Wilkin’s score  10 were more frequent in patients who
developed acute MR. Moderate MR occurred in 37(2.55%) patients and
mild MR in 41 patients (2.81%). Cardiac tamponade occurred in 19
patients (1.23%). Mild pericardial effusion was seen in 26patients and
BMV was deferred in the three of these patients. New onset atrial
ﬁbrillation was encountered in 14 (1.018%) patients during and
immediately after BMV. Five patients (0.3%) developed cerebrovas-
cular accident with signiﬁcant neurological deﬁcits following balloon
dilatation, which recovered gradually, and one patient had a transient
ischemic attack. Coiled wire got detached in the left atrium in one
patient and it was removed using a snare. There were 4 deaths. One
patient with severe RV dysfunction died on table. Another patient
died a week after failed BMV. Two patients died within a month of the
procedure due to non-cardiac illness. Vascular complications occurred
in 16 patients (1.1%) with retroperitoneal hematoma in one patient and
12 patients having groin hematoma. Femoral AV ﬁstula developed in
one patient, which required prolonged local compression. 2patients
had profunda artery pseudo aneurysm managed with local
embolization.
CONCLUSION The study shows excellent 30 -day outcomes for
balloon mitral valvuloplasty with mortality rate of 0.1%. Major mor-
bidities were acute severe MR (1.79%), cardiac tamponade (1.23%) and
vascular complications (1.1%). The occurrence of Atrial arrhythmias
and major strokes were noted at 1% and 0.3% respectively.
TCTAP A-180
Safety and Efﬁcacy of Thrombolysis for Stuck Valve in Rheumatic Heart
Disease - A Single Centre Experience
Arun prasath Palamalai,1 Sujal Nikhil Ramakrishnan,1
Anand Kumar gopi1
1Mahatma Gandhi Medical College and Research Institute, India
BACKGROUND Rheumatic heart disease causes signiﬁcant morbidity
and mortality in many of Asian and African countries. The resultant
corrective surgery for valve necessitates mechanical prosthetic valve
implantation at an earlier age to these patients. Prosthetic valve im-
plantation has its inherent problems and needs a proper oral anti-
coagulation with targeted INR throughout the life. Stuck valve is one
of the major complications encountered in this set of patients who
have suboptimal anticoagulation or interrupted anticoagulant ther-
apy. Thrombotic occlusion and restriction of valve leaﬂet movements
in mechanical valves often requires redo procedure which carries high
surgical risk. Medically managing such patient with early thrombol-
ysis and optimization of anticoagulation negates the need for redo
procedure, if successful. Herewith we present a series of cases
managed with thrombolysis for stuck valve Rheumatic heart disease
patients.
METHODS This retrospective study analyzed 16 patients of Rheumatic
Heart disease who underwent prosthetic valve implantation in mitral
and aortic position and presented with stuck valve in our center since
2012.The age group ranged from 22 to 60 years with 6 males and 10
females. Patients commonly presented with worsening dyspnea of
NYHA class III to acute pulmonary edema. After initial stabilization all
patients underwent detailed echocardiographic evaluation and stuck
valve is diagnosed if there is restricted prosthetic valve mobility with
higher gradient across the valves. Visible thrombus and pannus, if
any, were noted. Doubtful cases had ﬂuoroscopic examination in
catheterization laboratory to ascertain valve movement restriction.
The last follow-up INR, detailed drug history, drug compliance,
